Balaxi Pharma LTD
₹22.19▲ +0.06 (+0.27%)
BALAXI·NSE·Healthcare
Market Cap
121.95 Cr
PE Ratio
85.35
Volume
13,444
Day High - Low
22.60 - 21.80
52W High-Low
43.85 - 15.20
₹22.19▲ +0.06 (+0.27%)
Market Cap121.95 Cr
PE Ratio85.35
Volume13,444
Day High - Low22.60 - 21.80
52W High-Low43.85 - 15.20
Balaxi Pharma Ltd (BALAXI): company summary
The company's annual revenue fell 7.8% to ₹270 crore, while annual net profit dropped 94.3% to ₹1 crore.
Balaxi Pharma Ltd (BALAXI) is a micro-cap Healthcare company valued at ₹122 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Balaxi Pharma Ltd last traded at ₹22.19, modestly up 0.27% on the day.
- Recent developments
- On 2026-06-30, the company reported its latest quarter results, showing a significant jump in net profit to ₹1 crore, up from ₹0 crore in the same quarter a year earlier. The company's promoter holding remained at 65.99% as of 2026-06-30.
- Financial performance
- The company's annual revenue fell 7.8% to ₹270 crore, while annual net profit dropped 94.3% to ₹1 crore. The latest quarter saw revenue rise 14.1% to ₹81 crore and net profit surge 348.3% to ₹1 crore compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 85.3 times earnings, a premium to the Healthcare median of 32.0, 0.52 times book value. It yields 2.1%.
- Things to watch
- The company's net profit margin narrowed 8.0 percentage points to 0.5%, and return on equity fell to 0.6%. The stock is 50.7% below its 52-week high.
- Where it stands
- The company's latest quarter net profit rose sharply to ₹1 crore, but annual net profit fell 94.3% to ₹1 crore. The stock is 50.7% below its 52-week high.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
1.8/10
Poor
Fair Value
Sign in to see
ROE
0.57%
Weak
P/E
85.35x
Expensive
Debt / Equity
0.23
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
Day₹21.80
₹22.60
52W₹15.20
₹43.85
DocStoX take
Supported by risk (6.3), but held back by growth (0.5).
DocStoX score
Low confidence1.8
/10
Poor
Quality
Weak
ROE 0.6%
Valuation
Rich
P/E 85.3×
Growth
Flat
Revenue +3.2% 5Y CAGR
Risk
Moderate
D/E 0.23
Momentum
Weak
24% of 52-week range
At a glance
Market Cap
₹122 Cr
52W High / Low
₹44 / ₹15
Dividend Yield
2.15%
Promoter Holding
65.99%
EPS (TTM)
₹0.26
Book Value
₹45.12
Key highlights
- Low leverage — D/E 0.23
- Profit shrinking 48% a year
- Quality is weak (1.3/10)
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore BALAXI PHARMA LTD’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
BALAXI PHARMA LTD peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDLAURUS LABS LIMITEDCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare BALAXI PHARMA LTD with peers
Related tools & concepts
Value BALAXI PHARMA LTD with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing